Free Trial

Landore Resources (LND) Competitors

Landore Resources logo
GBX 4.07 -0.04 (-0.85%)
As of 10:58 AM Eastern

LND vs. AVO, FDP, TED, EMH, ATM, ZNWD, FAR, ARS, KAV, and GSP

Should you be buying Landore Resources stock or one of its competitors? The main competitors of Landore Resources include Advanced Oncotherapy (AVO), FD Technologies (FDP), Ted Baker (TED), European Metals (EMH), Andrada Mining (ATM), Zinnwald Lithium (ZNWD), Ferro-Alloy Resources (FAR), Asiamet Resources (ARS), Kavango Resources (KAV), and Gensource Potash (GSP).

Landore Resources vs.

Landore Resources (LON:LND) and Advanced Oncotherapy (LON:AVO) are both small-cap basic materials companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, profitability, dividends, institutional ownership, earnings, analyst recommendations, community ranking, valuation and risk.

3.2% of Landore Resources shares are owned by institutional investors. Comparatively, 17.8% of Advanced Oncotherapy shares are owned by institutional investors. 39.6% of Landore Resources shares are owned by insiders. Comparatively, 47.5% of Advanced Oncotherapy shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Landore Resources' average media sentiment score of 0.00 equaled Advanced Oncotherapy'saverage media sentiment score.

Company Overall Sentiment
Landore Resources Neutral
Advanced Oncotherapy Neutral

Advanced Oncotherapy's return on equity of -67.34% beat Landore Resources' return on equity.

Company Net Margins Return on Equity Return on Assets
Landore ResourcesN/A -217.63% -106.31%
Advanced Oncotherapy N/A -67.34%-11.73%

Landore Resources is trading at a lower price-to-earnings ratio than Advanced Oncotherapy, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Landore ResourcesN/AN/A-£3.77M-£1.16-3.50
Advanced OncotherapyN/AN/A-£32.60M-£0.07N/A

Advanced Oncotherapy received 122 more outperform votes than Landore Resources when rated by MarketBeat users. Likewise, 60.97% of users gave Advanced Oncotherapy an outperform vote while only 57.76% of users gave Landore Resources an outperform vote.

CompanyUnderperformOutperform
Landore ResourcesOutperform Votes
67
57.76%
Underperform Votes
49
42.24%
Advanced OncotherapyOutperform Votes
189
60.97%
Underperform Votes
121
39.03%

Landore Resources has a beta of -0.15, suggesting that its stock price is 115% less volatile than the S&P 500. Comparatively, Advanced Oncotherapy has a beta of 0.06, suggesting that its stock price is 94% less volatile than the S&P 500.

Summary

Advanced Oncotherapy beats Landore Resources on 8 of the 10 factors compared between the two stocks.

Remove Ads
Get Landore Resources News Delivered to You Automatically

Sign up to receive the latest news and ratings for LND and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LND vs. The Competition

MetricLandore ResourcesOther Industrial Metals & Mining IndustryMaterials SectorLON Exchange
Market Cap£12.95M£964.89M£2.97B£2.47B
Dividend Yield6.74%6.19%5.22%4.95%
P/E Ratio-3.5048.7175.81129.27
Price / SalesN/A20,234.3323,032,091,497,825,500.00236,356.18
Price / Cash21.0025.1624.3227.96
Price / Book4.097.565.314.44
Net Income-£3.77M£70.70M£155.26M£5.80B
7 Day Performance25.66%7.14%5.52%3.18%
1 Month Performance23.18%7.09%1.78%3.86%
1 Year Performance45.18%41.29%16.46%102.24%

Landore Resources Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LND
Landore Resources
N/AGBX 4.07
-0.9%
N/A+66.7%£12.95MN/A-3.506Gap Down
High Trading Volume
AVO
Advanced Oncotherapy
N/AN/AN/AN/A£9.50MN/A-25.003,900Gap Down
FDP
FD Technologies
N/AGBX 1,751.80
-1.3%
N/A+53.2%£389.28M£196.89M-12.1340,100
TED
Ted Baker
N/AN/AN/AN/A£202.71M£428.24M-5.69740
EMH
European Metals
N/AGBX 10.88
-1.1%
N/A-42.1%£44.74M£4.01M-38.56N/A
ATM
Andrada Mining
1.9914 of 5 stars
GBX 2.63
+1.2%
GBX 11
+318.3%
-47.4%£41.70M£20.54M-4.36219News Coverage
ZNWD
Zinnwald Lithium
N/AGBX 7.05
+0.7%
N/A+15.6%£40.03MN/A-15,782.4023Gap Up
FAR
Ferro-Alloy Resources
N/AGBX 6.30
-3.1%
N/A+40.6%£38.24M£5.72M-4.941,000Gap Down
ARS
Asiamet Resources
N/AGBX 0.92
-2.7%
N/A+46.2%£34.37MN/A-5.57N/AGap Up
KAV
Kavango Resources
N/AGBX 0.77
+6.2%
N/A-23.8%£29.38MN/A-6,707.3243Gap Up
GSP
Gensource Potash
N/AN/AN/AN/A£23.61MN/A-525.00N/A
Remove Ads

Related Companies and Tools


This page (LON:LND) was last updated on 4/17/2025 by MarketBeat.com Staff
From Our Partners